Invesco India Pharma and Healthcare Fund - Regular Fund - IDCW Plan
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 10-09-2026
AUM:
₹ 435.52 Cr
Expense Ratio
2.47%
Benchmark
BSE Healthcare TRI
ISIN
INF205KA1BV9
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Aditya Khemani
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Invesco India Pharma and Healthcare Fund - Regular Fund - IDCW Plan | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
9.42
Last change
0.32 (3.397%)
Fund Size (AUM)
₹ 435.52 Cr
Performance
-5.89% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Aditya Khemani
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Triparty Repo | 20.56 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 9.58 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 8.99 |
| Sai Life Sciences Limited | 8.63 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 8.03 |
| Manipal Health Enterprises Ltd. A** | 7.98 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.85 |
| GLOBAL HEALTH LIMITED EQ | 7.0 |
| Dr Agarwals Health Care Ltd. | 6.32 |
| CORONA REMEDIES PRIVATE LIMITED EQ | 6.13 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 87.01 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Invesco India Pharma and Healthcare Fund Reg IDCW | 0.0 |